FI885083A - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara l-prolinderivat. - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt anvaendbara l-prolinderivat. Download PDF

Info

Publication number
FI885083A
FI885083A FI885083A FI885083A FI885083A FI 885083 A FI885083 A FI 885083A FI 885083 A FI885083 A FI 885083A FI 885083 A FI885083 A FI 885083A FI 885083 A FI885083 A FI 885083A
Authority
FI
Finland
Prior art keywords
derivatives
group
prolinderivat
foerfarande foer
foer framstaellning
Prior art date
Application number
FI885083A
Other languages
English (en)
Finnish (fi)
Other versions
FI885083A0 (fi
Inventor
Pierre-Yves Fiez-Vandal
Original Assignee
Inorgan Sa Rech & Dev Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inorgan Sa Rech & Dev Pharma filed Critical Inorgan Sa Rech & Dev Pharma
Publication of FI885083A0 publication Critical patent/FI885083A0/fi
Publication of FI885083A publication Critical patent/FI885083A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Protection Of Transformers (AREA)
  • Measurement Of Force In General (AREA)
FI885083A 1987-11-03 1988-11-03 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara l-prolinderivat. FI885083A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8715228A FR2622581B1 (fr) 1987-11-03 1987-11-03 Nouveaux derives de l-proline, leur preparation et leurs applications biologiques

Publications (2)

Publication Number Publication Date
FI885083A0 FI885083A0 (fi) 1988-11-03
FI885083A true FI885083A (fi) 1989-05-04

Family

ID=9356437

Family Applications (1)

Application Number Title Priority Date Filing Date
FI885083A FI885083A (fi) 1987-11-03 1988-11-03 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara l-prolinderivat.

Country Status (12)

Country Link
US (1) US5212158A (de)
EP (1) EP0316218B1 (de)
JP (1) JP2694191B2 (de)
KR (1) KR0121793B1 (de)
AT (1) ATE94560T1 (de)
CA (1) CA1340227C (de)
DE (1) DE3884139T2 (de)
ES (1) ES2061710T3 (de)
FI (1) FI885083A (de)
FR (1) FR2622581B1 (de)
IE (1) IE64509B1 (de)
IL (1) IL88275A0 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69124274T2 (de) * 1990-02-27 1997-08-14 Agency Ind Science Techn Oligopeptide, sie enthaltende pharmazeutische und Futterzusammensetzung und Benützung von Oligopeptiden
JP3343181B2 (ja) * 1995-09-20 2002-11-11 生化学工業株式会社 桂皮酸誘導体
US6908900B2 (en) * 2001-01-17 2005-06-21 Zimmer & Associates Ag Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients
US7671029B2 (en) * 1999-08-06 2010-03-02 Immupharma Sa Compositions and methods for enhanced pharmacological activity of compositions comprising peptide drug substances
DE10105039A1 (de) * 2001-02-05 2002-08-08 Tell Pharm Ag Hergiswil Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
DE10105041A1 (de) * 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
DE10105038B4 (de) 2001-02-05 2005-07-07 Neurotell Ag Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
DE10105040A1 (de) * 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
US20050192228A1 (en) * 2001-02-05 2005-09-01 Jean Rapin Tripeptide derivatives for the treatment of neurodegenerative diseases
WO2003020321A2 (en) * 2001-09-06 2003-03-13 Zimmer Robert H Derivatives of pseudo-peptides, their preparation and their biological uses
US7252446B2 (en) * 2004-03-31 2007-08-07 Brother Kogoy Kabushiki Kaisha Image forming apparatus
FR2932179B1 (fr) * 2008-06-09 2012-12-07 I R D Procede microbiologique de synthese de derives cinnamoyl amides d'acides amines
UY32827A (es) * 2009-08-12 2011-02-28 Glaxo Group Ltd Inhibidores de catepsina c
SG192669A1 (en) 2011-02-11 2013-09-30 Glaxosmithkline Ip Dev Ltd Cathepsin c inhibitors
US20160045473A1 (en) * 2012-08-01 2016-02-18 Rory Powell Blake Biological Basis Of Adult Wellness
US20150038547A1 (en) * 2013-07-31 2015-02-05 Rory Powell Blake Biological Basis of Adult Wellness

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523598A (en) * 1975-03-08 1978-09-06 Reckitt & Colmann Prod Ltd Tripeptides
US4260682A (en) * 1979-04-04 1981-04-07 Ryan James W High sensitivity assays for angiotensin converting enzyme
EP0046742B1 (de) * 1980-08-25 1984-06-27 KabiVitrum AB Peptidsubstrate zum Bestimmen der Proteaseaktivität
US4499079A (en) * 1982-11-18 1985-02-12 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides
DE3481913D1 (de) * 1983-04-27 1990-05-17 Ici America Inc Prolin-derivate.
JPS63112597A (ja) * 1986-10-29 1988-05-17 Tokuyama Soda Co Ltd アミノ酸誘導体
US4804743A (en) * 1987-01-29 1989-02-14 Warner-Lambert Copmany Proline-containing renin inhibitors

Also Published As

Publication number Publication date
DE3884139T2 (de) 1994-05-05
KR0121793B1 (ko) 1997-11-27
US5212158A (en) 1993-05-18
DE3884139D1 (de) 1993-10-21
ES2061710T3 (es) 1994-12-16
KR890008091A (ko) 1989-07-08
EP0316218B1 (de) 1993-09-15
FR2622581A1 (fr) 1989-05-05
IE64509B1 (en) 1995-08-09
ATE94560T1 (de) 1993-10-15
FI885083A0 (fi) 1988-11-03
JPH01157998A (ja) 1989-06-21
CA1340227C (fr) 1998-12-15
FR2622581B1 (fr) 1990-02-16
IL88275A0 (en) 1989-06-30
JP2694191B2 (ja) 1997-12-24
IE883321L (en) 1989-05-03
EP0316218A1 (de) 1989-05-17

Similar Documents

Publication Publication Date Title
FI885083A0 (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara l-prolinderivat.
SE8303208D0 (sv) Heterocykliska foreningar
PT97993A (pt) Processo para a preparacao de derivados de amidas ciclicas e de composicoes farmaceuticas que os contem
DE10199003I1 (de) Substituierte Thiazolidinionderivate
SE8802173D0 (sv) Pyrimidine derivatives
ATE102193T1 (de) Thiazolidinedionederivate.
ATE118487T1 (de) Thiazolidinedionederivate.
ES8606336A1 (es) Un procedimiento para la preparacion de derivados de tiazol 2,4-disustituidos
ATE117999T1 (de) Zentralnervensystem wirksame chromanderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
FI800502A (fi) Difenylhydantoinderivat dessa innehaollande farmaceutiska kompositioner samt foerfarande foer framstaellning av dessa derivat
SE8403801L (sv) Nya bensotiazepiner med kardiovaskuler anvendbarhet, forfarande for framstellning derav och farmaceutiska kompositioner som innehaller dem
NO812355L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,1-benzoksazin-2-on-derivater
ATE241607T1 (de) Epoxybernsteinsäureamid-derivate
SE7605361L (sv) Sett att framstella nya n-substituerade fenylpiperazinderivat
NO177995C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3-dioksanderivater
ES2057415T3 (es) Derivados biciclicos.
ES2069249T3 (es) Derivados de imidazol, su procedimiento de preparacion y los compuestos farmaceuticos que los contienen.
IT1228454B (it) Derivati del 1-arilsolfonil 2 piperidone, loro procedimento di preparazione e loro impiego come farmaci.
ES2037783T3 (es) Procedimiento para la obtencion de 3-aminosidnoniminas substituidas.
ES2045514T3 (es) Utilizacion de derivados del cromano para el tratamiento de los estados depresivos.
ES2065192T3 (es) Nuevos nicotinatos de diacil-glicerol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
PT92175A (pt) Processo para a preparacao de 3-amino-sidnoniminas substituidas e de produtos intermediarios farmacologicamente activos
ATE2527T1 (de) Thienylbenzoesaeurederivate, verfahren zu ihrer herstellung und pharmazeutische praeparate auf basis dieser verbindungen.
MX9204220A (es) Bencimidazoles.
SE8802162L (sv) Nya aminoacylater av glycerolacetal

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: INORGAN SA, RECHERCHE & DéVELOPPEMENT